• 1
    Kappock, T.J. & Caradonna, J.P. (1996) Pterin-dependent amino acid hydroxylases. Chem. Rev. 96, 26592756.
  • 2
    Fitzpatrick, P.F. (1999) Tetrahydropterin-dependent amino acid hydroxylases. Ann. Rev. Biochem. 68, 355381.
  • 3
    Flatmark, T. & Stevens, R.C. (1999) Structural insight into the aromatic amino acid hydroxylases and their disease-related mutant forms. Chem. Rev. 99, 21372160.
  • 4
    Walker, S.J., Liu, X., Roskoski, R. & Vrana, K.E. (1994) Catalytic core of rat tyrosine hydroxylase: terminal deletion analysis of bacterially expressed enzyme. Biochim. Biophys. Acta 1206, 113119.
  • 5
    Dickson, P.W., Jennings, I.G. & Cotton, R.G.H. (1994) Delineation of the catalytic core of phenylalanine hydroxylase and identification of glutamate 286 as a critical residue for pterin function. J. Biol. Chem. 269, 2036920375.
  • 6
    Fitzpatrick, P.F. (1991) Steady-state kinetic mechanism of rat tyrosine hydroxylase. Biochemistry 30, 36583662.
  • 7
    Fitzpatrick, P.F. (1991) Studies of the rate-limiting step in the tyrosine hydroxylase reaction: alternate substrates, solvent isotope effects, and transition-state analogues. Biochemistry 30, 63866391.
  • 8
    Kumer, S.C. & Vrana, K.E. (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67, 443462.
  • 9
    Ramsey, A.J. & Fitzpatrick, P.F. (2000) Effects of phosphorylation on binding of catecholamines to tyrosine hydroxylase: specificity and thermodynamics. Biochemistry 39, 773778.
  • 10
    Erlandsen, H., Fusetti, F., Martinez, A., Hough, E., Flatmark, T. & Stevens, R.C. (1997) Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria. Nat. Struct. Biol. 4, 9951000.
  • 11
    Goodwill, K.E., Sabatier, C., Marks, C., Raag, R., Fitzpatrick, P.F. & Stevens, R. (1997) Crystal structure of tyrosine hydroxylase at 2.3 Å and its implications for inherited neurodegenerative diseases. Nat. Struct. Biol. 4, 578585.
  • 12
    Fusetti, F., Erlandsen, H., Flatmark, T. & Stevens, R.C. (1998) Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria. J. Biol. Chem. 237, 1696216967.
  • 13
    Goodwill, K.E., Sabatier, C. & Stevens, R.C. (1998) Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 Å resolution: self-hydroxylation of Phe300 and the pterin-binding site. Biochemistry 37, 1343713445.
  • 14
    Erlandsen, H., Flatmark, T. & Stevens, R.C. (2000) Crystal structure and site-specific mutagenesis of pterin-bound human phenylalanine hydroxylase. Biochemistry 39, 22082217.
  • 15
    Almås, B., Toska, K., Teigen, K., Groehn, V., Pfleiderer, W., Martinez, A., Flatmark, T. & Haavik, J. (2000) A kinetic and conformational study on the interaction of tetrahydropteridines with tyrosine hydroxylase. Biochemistry 39, 1367613686.
  • 16
    Meyer-Klaucke, W., Winkler, H., Trautwein, A.X., Nolting, H.F. & Haavik, J. (1996) Mössbauer, electron-paramagnetic-resonance and X-ray-absorption fine-structure studies of the iron environment in recombinant human tyrosine hydroxylase. Eur. J. Biochem. 241, 432439.
  • 17
    Erlandsen, H., Flatmark, T., Stevens, R.C. & Hough, E. (1998) Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 Å resolution. Biochemistry 37, 1563815646.
  • 18
    Schünemann, V., Meier, C., Meyer-Klaucke, W., Winkler, H., Trautwein, A.X., Knappskog, P.M., Toska, K. & Haavik, J. (1999) Iron coordination geometry in full-length, truncated, and dehydrated forms of human tyrosine hydroxylase studied by Mössbauer and X-ray absorption spectroscopy. J. Biol. Inorg. Chem. 4, 223231.
  • 19
    Daubner, S.C., Hillas, P.J. & Fitzpatrick, P.F. (1997) Characterization of chimeric pterin-dependent hydroxylases: contributions of the regulatory domains of tyrosine and phenylalanine hydroxylase to substrate specificity. Biochemistry 36, 1157411582.
  • 20
    Daubner, S.C. & Fitzpatrick, P. (1999) Site-directed mutants of charged residues in the active site of tyrosine hydroxylase. Biochemistry 38, 44484454.
  • 21
    Daubner, S.C., Melendez, J. & Fitzpatrick, P. (2000) Reversing the substrate specificities of phenylalanine and tyrosine hydroxylase: aspartate 425 of tyrosine hydroxylase is essential for 1-DOPA formation. Biochemistry 39, 96529661.
  • 22
    Andersen, O.A., Flatmark, T. & Hough, E. (2002) Crystal structure of the ternary complex of the catalytic domain of human phenylalanine hydroxylase with tetrahydrobiopterin and 3-(2-thienyl)-l-alanine, and its implications for the mechanism of catalysis and substrate activation. J. Mol. Biol. 320, 10951108.
  • 23
    Teigen, K., Frøystein, N. & Martinez, A. (1999) The structural basis of the recognition of phenylalanine and pterin cofactors by phenylalanine hydroxylase: implications for the catalytic mechanism. J. Mol. Biol. 294, 807823.
  • 24
    Jiang, G.C.-T., Yohrling, G.J., Schmitt, I.V.J.D. & Vrana, K.E. (2000) Identification of substrate orienting and phosphorylation sites within tryptophan hydroxylase using homology-based molecular modeling. J. Mol. Biol. 302, 10051017.
  • 25
    Rarey, M., Kramer, B., Lengauer, T. & Klebe, G. (1996) A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 261, 470489.
  • 26
    Brooks, B.R., Bruccoleri, R.E., Olafson, B.D., States, D.J., Swaminathan, S. & Karplus, M. (1983) CHARMm: a program for macromolecular energy, minimization and dynamics calculation. J. Comp. Chem. 4, 187217.
  • 27
    Hoffmann, D., Kramer, B., Washio, T., Steinmetzer, T., Rarey, M. & Lengauer, T. (1999) Two-stage method for protein-ligand docking. J. Med. Chem. 42, 44224433.
  • 28
    Ellis, H.R., Daubner, S.C., McCulloch, R.I. & Fitzpatrick, P.F. (1999) Phenylalanine residues in the active site of tyrosine hydroxylase: mutagenesis of Phe300 and Phe309 to alanine and metal ion-catalyzed hydroxylation of Phe300. Biochemistry 38, 1090910914.
  • 29
    Bohm, H.-J. (1994) The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J. Comput. Aided Mol. Des. 8, 243256.
  • 30
    Warwicker, J. & Watson, H.C. (1982) Calculation of the electric potential in the active site cleft due to alpha-helix dipoles. J. Mol. Biol. 157, 671679.
  • 31
    Klapper, I., Hagstrom, R., Fine, R. & Honig, B. (1986) Focusing of electric fields in the active site of Cu-Zn superoxide dismutase: effects of ionic strength and amino-acid modification. Proteins 1, 4759.
  • 32
    Hoffmann, D., Washio, T., Gessler, K. & Jacob, J. (1998) Tackling concrete problems in molecular biophysics using Monte Carlo and related methods: glycosylation, folding, solvation. In: Proceedings of the Workshop on: Monte Carlo Approach to Biopolymers and Protein Folding (Grassberger, P., Barkema, G. & Nadler, W., eds), pp. 153170. World Scientific Publishing, River Edge, Singapore.
  • 33
    Kobe, B., Jennings, I.G., House, C.M., Michell, B.J., Goodwill, K.E., Santarsiero, B.D., Stevens, R.C., Cotton, R.G.H. & Kemp, B.C. (1999) Structural basis of autoregulation of phenylalanine hydroxylase. Nat. Struct. Biol. 6, 442448.
  • 34
    Svensson, E., Eisensmith, R.C., Dworniczak, B., van Dobeln, U., Hagenfeld, L., Horst, J. & Woo, S.L. (1992) Two missense mutations causing mild hyperphenylalaninemia associated with DNA haplotype 12. Hum. Mutat. 1, 129137.
  • 35
    Nowacki, P., Byck, S., Prevost, L. & Scriver, C.R. (1998) PAH Mutation Analysis Consortium Database: 1997. Prototype for relational locus-specific mutation databases. Nucleic Acids Res. 26, 220225.
  • 36
    Martinez, A., Vageli, O., Pfleiderer, W. & Flatmark, T. (1998) Proton NMR studies on the conformation of the pterin cofactor bound at the active site of recombinant human tyrosine hydroxylase. Pteridines 9, 4452.
  • 37
    Meng, E.C., Schichet, B.K. & Kuntz, I.D. (1992) Automated docking with grid-based energy evaluation. J. Comput. Chem. 13, 505524.
  • 38
    Michaud-Soret, I., Andersson, K.K., Que, L. Jr & Haavik, J. (1995) Resonance Raman studies of catecholate and phenolate complexes of recombinant human tyrosine hydroxylase. Biochemistry 34, 55045510.
  • 39
    Almås, B., Le Bourdelles, B., Flatmark, T., Mallet, J. & Haavik, J. (1992) Regulation of recombinant human tyrosine hydroxylase isozymes by catecholamine binding and phosphorylation. Structure/activity studies and mechanistic implications. Eur. J. Biochem. 209, 249255.
  • 40
    Haavik, J., Martinez, A., Olafsdottir, S., Mallet, J. & Flatmark, T. (1992) The incorporation of divalent metal ions into recombinant human tyrosine hydroxylase apoenzymes studied by intrinsic fluorescence and 1H-NMR spectroscopy. Eur. J. Biochem. 210, 2331.
  • 41
    Haavik, J., Almås, B. & Flatmark, T. (1997) Generation of reactive oxygen species by tyrosine hydroxylase: a possible contribution to the degeneration of dopaminergic neurons? J. Neurochem. 68, 328332.
  • 42
    Blum, D., Torch, S., Lambeng, N., Nissou, M., Benabid, A.L., Sadoul, R. & Verna, J.M. (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Progr. Neurobiol. 65, 135172.